Allergic Rhinitis: Beltavac® Immunotherapy

We are studying the effectiveness and safety of Beltavac®, a new immunotherapy, for people with allergic rhinitis caused by house dust mites. The trial will also look at how it affects allergy symptoms and overall quality of life.

>2 yearsConfirmation phase (III)Investigational MedicinesInjectionAllergologyOphthalmologyOtolaryngology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Novo-Helisen Dermatophagoides Farinae + Dermatophagoides Pteronyssinus
Novo-Helisen is a treatment used to reduce allergic reactions to house dust mites, helping relieve hay fever and asthma symptoms.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Aluminium Hydroxide
Aluminium hydroxide is a substance that neutralizes stomach acid to relieve heartburn, indigestion, and acid-related discomfort.
Dermatophagoides Farinae
Dermatophagoides farinae is a house-dust-mite allergen used for testing and desensitizing people with dust-mite allergies.
Dermatophagoides Farinae Extract
Dermatophagoides farinae extract is a house-dust-mite allergen extract used to diagnose and reduce allergic reactions like hay fever and asthma.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Beltavac

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Alk (Alutard Sq)
Alk-Depot Sq 802
Allergovit

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Germans Trias I Pujol
Allergology
Badalona, Spain
Hospital Universitario De Navarra
Allergology
Barañáin, Spain
Hospital Fundació Sant Pere Claver
Allergollogy
Barcelona, Spain
Sponsor: Probelte Pharma S.L.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.